Literature DB >> 20813980

Tissue oxidative metabolism after extreme hemodilution with PEG-conjugated hemoglobin.

Pedro Cabrales1, Fantao Meng, Seetharama A Acharya.   

Abstract

NADH-localized fluorometry was used as a noninvasive technique to monitor changes in the energy state of intact tissue (muscle and connective tissue), without anesthesia, as a function of blood plasma O(2)-carrying capacity in the hamster window chamber model. Acute moderate isovolemic hemodilution was induced by two isovolemic hemodilution steps: in the first step, 6% 70-kDa dextran (Dex70) was used to induce an acute anemic state (18% Hct); in the second step, exchange transfusion of polyethylene glycol (PEG) maleimide-conjugated Hb (4 g/dl, PEG-Hb) or Dex70 (6 g/dl) was used to reduce erythrocytes to 75% of baseline (11% Hct). PEG-Hb had six copies of PEG (5 kDa) conjugated to each human Hb (0.48 g PEG/g Hb) through extension arm-facilitated chemistry. Systemic parameters, microvascular perfusion, functional capillary density, intravascular and interstitial Po(2), and intracellular NADH fluorescence were monitored. Mean arterial blood pressure after extreme hemodilution was statistically significantly reduced for Dex70 compared with PEG-Hb. The presence of PEG-Hb in the circulation maintained positive acid-base balance. While microvascular blood flows were not different, functional capillary density was significantly higher for PEG-Hb than Dex70. Arteriolar Po(2) was higher in the presence of PEG-Hb than Dex70, but tissue and venular Po(2) were not different. Cellular energy metabolism (intracellular O(2)) in the tissues was improved with PEG-Hb. Moderate hemodilution to 18% Hct (6.4 g Hb/dl) brings tissue O(2) delivery to the verge of inadequacy. Extreme hemodilution to 11% Hct (3.7 g Hb/dl) produces tissue anoxia, and high-O(2)-affinity PEG-Hb (Po(2) at which blood is 50% saturated with O(2) = 4 Torr, 1.1 g Hb/dl) only partially decreases anaerobic metabolism without increasing tissue Po(2).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813980      PMCID: PMC3006400          DOI: 10.1152/japplphysiol.00344.2010

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  40 in total

1.  Critical PO(2) of skeletal muscle in vivo.

Authors:  K N Richmond; R D Shonat; R M Lynch; P C Johnson
Journal:  Am J Physiol       Date:  1999-11

Review 2.  How to randomise.

Authors:  D G Altman; J M Bland
Journal:  BMJ       Date:  1999-09-11

3.  pO(2) measurements by phosphorescence quenching: characteristics and applications of an automated system.

Authors:  Heinz Kerger; Gesine Groth; Armin Kalenka; Peter Vajkoczy; Amy G Tsai; Marcos Intaglietta
Journal:  Microvasc Res       Date:  2003-01       Impact factor: 3.514

4.  A method for the localization of sites for oxidative phosphorylation.

Authors:  B CHANCE; G R WILLIAMS
Journal:  Nature       Date:  1955-08-06       Impact factor: 49.962

Review 5.  Therapeutic applications of polymeric artificial cells.

Authors:  Thomas Ming Swi Chang
Journal:  Nat Rev Drug Discov       Date:  2005-03       Impact factor: 84.694

6.  MP4, a new nonvasoactive PEG-Hb conjugate.

Authors:  Kim D Vandegriff; Ashok Malavalli; Jerod Wooldridge; Jeff Lohman; Robert M Winslow
Journal:  Transfusion       Date:  2003-04       Impact factor: 3.157

7.  Effects of extreme hemodilution with hemoglobin-based O2 carriers on microvascular pressure.

Authors:  Pedro Cabrales; Amy G Tsai; Robert M Winslow; Marcos Intaglietta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-01-06       Impact factor: 4.733

8.  Early difference in tissue pH and microvascular hemodynamics in hemorrhagic shock resuscitation using polyethylene glycol-albumin- and hydroxyethyl starch-based plasma expanders.

Authors:  Pedro Cabrales; Parimala Nacharaju; Belur N Manjula; Amy G Tsai; Seetharama A Acharya; Marcos Intaglietta
Journal:  Shock       Date:  2005-07       Impact factor: 3.454

9.  Altered NADH and improved function by anesthetic and ischemic preconditioning in guinea pig intact hearts.

Authors:  Matthias L Riess; Amadou K S Camara; Qun Chen; Enis Novalija; Samhita S Rhodes; David F Stowe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-07       Impact factor: 4.733

10.  Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics.

Authors:  Amy G Tsai; Kim D Vandegriff; Marcos Intaglietta; Robert M Winslow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-06-12       Impact factor: 4.733

View more
  2 in total

1.  GBT1118, a potent allosteric modifier of hemoglobin O2 affinity, increases tolerance to severe hypoxia in mice.

Authors:  Kobina Dufu; Ozlem Yalcin; Eilleen S Y Ao-Ieong; Athiwat Hutchaleelala; Qing Xu; Zhe Li; Nicholas Vlahakis; Donna Oksenberg; Josh Lehrer-Graiwer; Pedro Cabrales
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-05-19       Impact factor: 4.733

2.  Polymerized human hemoglobin facilitated modulation of tumor oxygenation is dependent on tumor oxygenation status and oxygen affinity of the hemoglobin-based oxygen carrier.

Authors:  Donald A Belcher; Alfredo Lucas; Pedro Cabrales; Andre F Palmer
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.